JPRN-jRCT2080222319未知1 期
A Single Dose Study to Evaluate the Pharmacokinetics and Glucodynamics of insulin peglispro (LY2605541) in Healthy Male Japanese Subjects
试验速览
- 阶段
- 1 期
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- >= 20age old 至 <= 45age old（—）
- 性别
- Male
入选标准
- •Participants are overtly healthy male Japanese.
- •Participants have Body Mass Index (BMI) between 18.5 and 25.0 kilogram per square meter (kg/m^2), inclusive.
排除标准
- •Participants have known allergies to insulin peglispro, related compounds.
- •Participants have a fasting venous blood glucose >108 milligram per deciliter (mg/dL) (>6 millimole per liter [mmol/L]).
研究者
相似试验
尚未招募
不适用
A clinical trial to study pharmacokinetics of ALDP 001 in the healthy adult human subjectsCTRI/2022/05/042349Alkem Laboratories Limited
进行中（未招募）
不适用
A Study to Assess the Pharmacokinetics, Safety and Tolerability of Sitagliptin in AdolescentsType 2 Diabetes MellitusEUCTR2014-004993-40-Outside-EU/EEAMerck & Co., Inc.35
进行中（未招募）
1 期
PK Study in Adolescents and Young Adults Treated with GlucocorticoidsMedDRA version: 18.1Level: PTClassification code 10031282Term: OsteoporosisSystem Organ Class: 10028395 - Musculoskeletal and connective tissue disordersOsteoporosisEUCTR2012-003414-14-GBMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as19
进行中（未招募）
不适用
PK Study in Adolescents with Glucocorticoid-Induced OsteoporosisosteoporosisEUCTR2012-003414-14-Outside-EU/EEAMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc. (hereafter referred to as16
进行中（未招募）
1 期
PK Study in Adolescents and Young Adults Treated with GlucocorticoidsOsteoporosisEUCTR2012-003414-14-ITMerck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc.24